Publications by authors named "Stewart Tepper"

Claim this Profile
S
State of the art in the management of migraine-A response to the American College of Physicians migraine preventive treatment guideline.
Andrew C Charles, Stewart J Tepper, Jessica Ailani

Headache· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Headache society evidence-based guidelines on the use of non-invasive neuromodulation devices for the acute and preventive treatment of migraine.
Hsiangkuo Yuan, Serena L Orr, Mohammad A M Al-Karagholi, Messoud Ashina, Fred Cohen, Stewart J Tepper

Cephalalgia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rimegepant 75 mg for acute treatment of migraine: a pooled analysis of four randomized, placebo-controlled trials.
Stewart J Tepper, Jelena M Pavlovic, Shengyuan Yu, Richard B Lipton, Glenn Pixton

Postgrad Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo-Controlled Study.
Stewart J Tepper, David W Dodick, Michel Lanteri-Minet, David Dolezil, Raquel Gil-Gouveia

Eur J Neurol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Eptinezumab in Episodic Cluster Headache: A Randomized Clinical Trial.
Rigmor H Jensen, Cristina Tassorelli, Stewart J Tepper, Andrew Charles, Peter J Goadsby

JAMA Neurol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of the persistence of acute treatment with rimegepant versus oral triptans in patients with migraine: A retrospective analysis of US claims data.
Stewart J Tepper, Aaron Jenkins, Carl Henriksen, Feng Dai, Jo Atkinson

Cephalalgia· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database-based observational cohort study.
David W Dodick, Stewart J Tepper, Jessica Ailani, Ani C Khodavirdi, Nico Pannacciulli

Headache· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trial.
Cristina Tassorelli, Rigmor H Jensen, Peter J Goadsby, Andrew C Charles, Stewart J Tepper

Lancet Neurol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nutraceuticals and Headache 2024: Riboflavin, Coenzyme Q10, Feverfew, Magnesium, Melatonin, and Butterbur.
Stewart J Tepper, Katharine Tepper

Curr Pain Headache Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study.
Stewart J Tepper, Detlef Albrecht, Jessica Ailani, Louis Kirby, Shannon Strom

CNS Drugs· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life measures.
Stewart J Tepper, Merle L Diamond, Joe Hirman, Divya Asher, Damian Fiore

J Neurol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled Trial.
Stewart J Tepper, David W Dodick, Michel Lanteri-Minet, David Dolezil, Raquel Gil-Gouveia

JAMA Neurol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns of patients with migraine eligible for anti-CGRP pathway monoclonal antibodies.
Ani C Khodavirdi, Jasjit K Multani, Sam S Oh, Fiston Vuvu, Mark E Bensink, Stewart J Tepper

Front Neurol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacks.
Richard B Lipton, Jessica Ailani, Kathleen Mullin, Jelena M Pavlovic, Stewart J Tepper

Headache· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study.
Patricia Pozo-Rosich, Messoud Ashina, Stewart J Tepper, Sidsel Jensen, Line Pickering Boserup

Neurol Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on 2022 guidelines on clinical trial design in cluster headache and further suggestions.
Ioana Medrea, Stewart J Tepper, Donliang Wang, Paul G Mathew, Mark Burish

J Headache Pain· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of medication overuse headache.
Domenico D'Amico, Licia Grazzi, Stewart J Tepper

Handb Clin Neurol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained response of galcanezumab in migraine prevention: Patient-level data from a post hoc analysis in patients with episodic or chronic migraine.
Stewart J Tepper, Yan Dong, Maurice Vincent, Linda A Wietecha

Headache· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non-interventional study using claims data from the United States.
Stewart J Tepper, Todd J Schwedt, Pamela Vo, Jeffrey Thompson, Parth Joshi

Headache· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial.
Messoud Ashina, Stewart J Tepper, Astrid Gendolla, Bjørn Sperling, Anders Ettrup

J Headache Pain· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review.
Andrew M Blumenfeld, Richard B Lipton, Stephen Silberstein, Stewart J Tepper, Larry Charleston

Neurol Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serotonin syndrome in the acute treatment landscape of migraine: the lasmiditan experience.
Andrew Blumenfeld, Stewart J Tepper, Rashna Khanna, Erin Doty, Maurice Vincent

Front Neurol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Brief Review of Gepants.
Diana Li, Jessica Abreu, Stewart J Tepper

Curr Pain Headache Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis.
Stewart J Tepper, Richard B Lipton, Stephen D Silberstein, David Kudrow, Messoud Ashina

Headache· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression.
Stewart J Tepper, Jessica Cirillo, Edward Kim, Gil L'Italien, Julie M Tweedie

J Headache Pain· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis